Navigation Links
Basic research leads to a novel cancer therapy

cancer development. The Max Planck scientists showed that tumour tissue just a few cubic millimetres in size can create vascular endothelial growth factor (VEGF), which triggers blood vessel development.

Ullrich found some of the most important evidence in research on animals, conducted with colleagues Birgit Millauer and the late Werner Risau, formerly of the Max Planck Institute of Neurobiology. There is a receptor specific to VEGF, called Flk-1/VEGFR2, found only in endothelial cells which are the building stones of new blood vessels. When Flk-1/VEGFR2 is made inoperative, this blocks the development of tumours. If no blood vessels are created in tumour tissue, the tumour fails to grow. This discovery led to the invention of what are called angiogenesis inhibitors (angiogenesis is the process of blood vessel formation).

Ullrich and the Max Planck Society, in co-operation with New York University, founded SUGEN, Inc. in California in 1991. SUGEN is the first biotechnology company with roots in the Max Planck Society. The firm developed chemical substances which block Flk-1/VEGFR2 in endothelial cells. At the end of the 1990s SUGEN was taken over by Pharmacia, which itself was bought by Pfizer in 2003. Development of the project continued at Pfizer. SUTENT® (active ingredient Sunitinib) has now reached the market as a multi-targeted tyrosine kinase inhibitor, which blocks both the building of blood vessels in tumours as well as other illness-related enzymes in tumour cell signalling networks.

Clinical studies with GIST patients looked into their ability to tolerate Sunitinib, as well as its effectiveness on them. Some of these patients had already been treated with Imatinib, but their tumours continued to develop. Others were not able to tolerate Imatinib at all. Still other patients had advanced renal cell carcinoma with failed available treatment. In the case of the GIST patients, it took four times longer for tumours to renew growth when
'"/>

Source:Max-Planck-Gesellschaft


Page: 1 2 3 4

Related biology news :

1. Distributed Basic Local Alignment Search Toolkit (W.ND-BLAST)
2. Basic work on E. coli identifies two new keys to regulation of bacterial gene expression
3. Columbia research lifts major hurdle to gene therapy for cancer
4. U of M researcher examines newly emerging deadly disease
5. NYU researchers simulate molecular biological clock
6. First atlas of key brain genes could speed research on cancer, neurological diseases
7. New research questions basic tenet of neuron function
8. Vital step in cellular migration described by UCSD medical researchers
9. ASU researchers finds novel chemistry at work to provide parrots vibrant red colors
10. UCSD researchers maintain stem cells without contaminated animal feeder layers
11. Why do insects stop breathing? To avoid damage from too much oxygen, say researchers
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Basic research leads novel cancer therapy

(Date:7/25/2014)... Nearly 600 scientists from 25 countries and ... Meeting organized by the Genetics Society of America ... in Seattle. The conference will feature close to ... results on topics including gene expression and regulation, ... technologies, evolution, aging, and a variety of diseases. ...
(Date:7/25/2014)... pleiotropic factor characterized by the existence of numerous ... confer to the protein deeply different characteristics. NRG1 ... occurring during development and the different phases occurring ... axon regrowth, remyelination and target reinnervation, Researchers at ... the soluble NRG1 upregulation observed in Schwann cells ...
(Date:7/25/2014)... Institute for Medical Research have identified the functions ... crucial to triggering the mating process in mice. , ... mouse detect pheromones that indicate when a female is ... if the female mouse is ovulating and ready to ... mating. Stowers, researchers believe mice developed this system through ...
Breaking Biology News(10 mins):Yeast meeting to showcase latest breakthroughs in genetics and molecular biology 2It takes two to court 2It takes two to court 3
... new cases of the genetic disease Noonan Syndrome are so ... normal father,s production of sperm carrying the disease trait. ... sperm stem cell it makes that cell more likely to ... then is more likely to have an affected child because ...
... average 5-year survival for colorectal cancer (CRC) is less ... if detected early. A new non-invasive test has been ... tissues and blood sera. This test detected 87% of ... difference between early and advanced stages, while correctly identifying ...
... must minimize the humanness of their enemies in order to ... by feelings of empathy for opponents. But indifference to the ... provide troops with a better path back to healthy civilian ... hypothesis is based on new work showing how the brain ...
Cached Biology News:Biomarker identification may lead to new noninvasive test for colorectal cancer detection 2A way of thinking may enable battle but prevent war crimes 2A way of thinking may enable battle but prevent war crimes 3A way of thinking may enable battle but prevent war crimes 4A way of thinking may enable battle but prevent war crimes 5A way of thinking may enable battle but prevent war crimes 6
(Date:7/25/2014)... Biotech Ltd. (Nasdaq: SVA ), a leading provider ... announced that it will release its unaudited financial results for ... on Thursday, August 14, 2014 EDT. The Company will host ... August 15, 2014, at 8:00 a.m. EDT (Friday, August 15, ... Company,s financial results and provide an update on recent corporate ...
(Date:7/24/2014)... , July 24, 2014  Asterias Biotherapeutics, Inc. ... emerging field of regenerative medicine, announced today that ... presentation to investors on Tuesday, July 29, 2014, ... presentation will include an overview of Asterias, business ... webcast, visit http://www.ustream.tv/channel/asterias-biotherapeutics at least 15 ...
(Date:7/24/2014)... Professor of Engineering at the University of Delaware, ... problems in energy engineering, environmental sustainability and electronics. ... porous rock with a well-defined, crystalline structure. At ... precisely decided that zeolites can separate molecules with ... angstrom (one-tenth of a nanometer), making them useful ...
(Date:7/24/2014)... 24, 2014 SRI International has been awarded ... Institute of Allergy and Infectious Diseases (NIAID), part of ... of potential therapies for HIV infection and AIDS. The ... and AIDS and the complications and opportunistic infections associated ... sexual transmission of HIV. According to ...
Breaking Biology Technology:Sinovac to Host Conference Call to Report Second Quarter 2014 Unaudited Financial Results 2Asterias Biotherapeutics Announces Live Investor Webcast 2Asterias Biotherapeutics Announces Live Investor Webcast 3Asterias Biotherapeutics Announces Live Investor Webcast 4University of Delaware researcher describes new approach for creating organic zeolites 2National Institute of Allergy and Infectious Diseases Awards SRI International Contract to Study New Therapies for HIV and AIDS 2National Institute of Allergy and Infectious Diseases Awards SRI International Contract to Study New Therapies for HIV and AIDS 3
... ... ... Paul LaViolette to retire from Company, NATICK, Mass., ... Jim Tobin will be extending his tenure at the Company. The Company,said Tobin plans to remain ...
... Calif., June 3 Masimo Corporation,(Nasdaq: MASI ... oximetry, today announced,that it is scheduled to present ... at The Ritz Carlton, Laguna Nigel, in Dana ... p.m. PT. Joe E. Kiani, Chairman and,CEO, will ...
... ANGELES, June 3 Growing Generations, the nation,s,largest surrogacy ... egg donation services to men with HIV and allows ... The new program is made possible due to ... as well as the implementation of recent California,legislation enacted ...
Cached Biology Technology:Boston Scientific Announces CEO Jim Tobin to Extend Tenure 2Boston Scientific Announces CEO Jim Tobin to Extend Tenure 3Boston Scientific Announces CEO Jim Tobin to Extend Tenure 4Boston Scientific Announces CEO Jim Tobin to Extend Tenure 5Masimo to Present at Goldman Sachs 29th Annual Global Healthcare Conference 2Growing Generations Announces Surrogacy Program for Men with HIV 2
Anti-human C5/C5b, Clone 568, Monoclonal Antibody...
Gentamicin sulfate, 5g...
... [EP282Y] to Asparagine synthetase ( ... applications). Antigen: ... residues in the C-terminus of ... Entrez GeneID: 440 ...
Anti-gamma Glutamyl Transferase (gammaGT) Host: mouse monoclonal Species Reactivity: human Applications: WB, IP, FC Storage: 4C...
Biology Products: